Inici › EPOC › Florida › Miami
Assaigs clínics de EPOC a Miami, FL
18 estudis de EPOC busquen participants en centres de Miami i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutantFase 3
- Research Site, Miami
- Research Site, Miami
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutantFase 3
- Elite Clinical Research - Miami- Site Number : 8400167, Miami
- DL Research Solutions- Site Number : 8400140, Miami
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
- i 3 més
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
ReclutantFase 2
- Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
ReclutantFase 3
- GSK Investigational Site, Miami
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
ReclutantFase 2
- Millennium Medical Research - Miami, Miami
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutantFase 3
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
- MCR Research- Site Number : 8400004, Miami
- Nuren Medical & Research Center- Site Number : 8400030, Miami
- i 1 més
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
ReclutantFase 4
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ReclutantFase 2
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
- i 2 més
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
ReclutantFase 3
- Research Site, Miami
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutantFase 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutantFase 2/3
- Reed Medical Research, Miami
Rademikibart IV for Acute Asthma and COPD Exacerbation
ReclutantFase 2
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
ReclutantFase 3
- GC2501 Study Site 105, Miami
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutantFase 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Reclutant
- University of Miami, Miami
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ReclutantFase 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- i 4 més
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
ReclutantFase 3
- GSK Investigational Site, Miami
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Reclutant
- Reliable Research, Inc., Miami
- NewGen Health Group, Miami
Assaigs de EPOC en altres ciutats
- Philadelphia, PA23 estudis
- Birmingham, AL17 estudis
- Boston, MA17 estudis
- Houston, TX15 estudis
- Orlando, FL15 estudis
- Baltimore, MD14 estudis
- Chicago, IL14 estudis
- Dallas, TX12 estudis
- Pittsburgh, PA12 estudis
- New York City, NY11 estudis
- Ann Arbor, MI10 estudis
- Winston-Salem, NC9 estudis
Altres estudis a Miami
- Càncer de mama42 estudis
- Càncer (tots els tipus)36 estudis
- Càncer de pulmó de cèl·lules no petites31 estudis
- Càncer de pròstata27 estudis
- Obesitat27 estudis
- Leucèmia mieloide aguda24 estudis
- Càncer metastàtic24 estudis
- Càncer d'ovari23 estudis
- Sobrepès23 estudis
- Mieloma múltiple21 estudis
- Colitis ulcerosa21 estudis
- Malaltia d'Alzheimer20 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.